Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. - Wikidata - awgldk - TriplyDB

Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

http://www.wikidata.org/entity/Q36092102

about

Effects of Oxidative Stress on Mesenchymal Stem Cell Biology Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma TPL2 kinase regulates the inflammatory milieu of the myeloma niche IAP antagonists induce anti-tumor immunity in multiple myeloma.Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells.Multiple myeloma macrophages: pivotal players in the tumor microenvironment.Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Induction of malignant plasma cell proliferation by eosinophils The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells.Haematological malignancies: at the forefront of immunotherapeutic innovation.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss.Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone Immunological dysregulation in multiple myeloma microenvironment.Targeting the bone marrow microenvironment in multiple myeloma.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.NF-Kβ Activation in U266 Cells on Mesenchymal Stem Cells To b(ortezomib) or not to be: the stroma's the thing.Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.Targeting the Bone Marrow Microenvironment.A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.Trial Watch: Lenalidomide-based immunochemotherapy.Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models.Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model.A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma.Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias.

P2860

Q26740408-D7FAE73B-CDAB-4D83-93F3-3458997840F1 Q27027729-C74499EB-0193-4F31-84B0-9B1B99994404 Q33714724-BEA0715B-F272-4CCB-ADBC-4C692E6B50DE Q33914862-BAD72966-2E21-406A-88E9-C5893284B5BD Q34036138-DDA4477B-46EC-49EC-9935-E77068010B6C Q34060079-D5D23BFD-FB52-4B44-8AC4-AA4B7050A92B Q34329152-6CD95558-0949-45F0-827B-737FB6DD7FF5 Q34329242-A0D80590-E0B9-435E-9EBB-9B94530A5396 Q34876626-39C2E9D3-6441-4678-A147-0170430CACB7 Q35648024-235BC928-B0FE-4DC1-B5A5-95B97C8D27D7 Q35766816-1623FA2E-BD32-40EB-969B-D332CDA14FF9 Q35880618-410AA2B9-019E-4285-9D1C-16D6453DD1F6 Q36447553-53845F10-C2AC-4898-BD6B-829A1338344B Q36573949-FAEA1194-12C6-4BE9-B40F-0DD0C757E341 Q36674532-B3128A1B-D282-4AED-9F96-6B4466C7C807 Q37144501-6BACB95F-DE07-41D7-AB6F-760BC4534270 Q37628186-9094B696-71A7-42CA-83B7-C8690423D40C Q38228353-F1ED0BE4-C899-4EAD-A17E-076EC74E93C1 Q38289041-2222882B-8A84-4694-B78F-93144BB34F1A Q38299932-127CCABB-8693-4787-B68C-A9195A338E82 Q38708402-748B0BF4-6D98-446E-AAE3-05038D7432BF Q38739207-79236308-63C1-4606-A38D-5EAE6D6F2EA5 Q38762531-E6CD69E2-0B12-4946-A8C8-BD0D8415223A Q38781397-33859CB6-3A72-4886-B9ED-71898C46E6D5 Q38966197-0664A77E-69B3-42C4-83FE-10635EA43F04 Q38970585-A214CCBF-465B-4D5E-AEB6-6EEF6EA78373 Q39030703-062A605D-DC2E-49E6-B44E-9422C6EA6A56 Q39093915-AAE9A54B-0394-426E-893B-982159644499 Q39136762-9DFBE550-9C55-4268-B80A-9D4CFEB05967 Q39235262-E2BD93A6-5D9B-44B9-A1A7-EE4B6D3800DF Q41591687-C1B13979-B4C5-439E-9B2F-EF002F89F6F8 Q41699059-575B9C84-ECDD-434D-AF30-3BB6FF021C09 Q42158465-4D9A4A1F-E022-4142-B187-84E12E70399E Q42737828-7A2936A8-CDDC-47C6-8438-C20CEC00CCE0 Q42775866-24A928D2-6B23-4E9B-BBA8-96249142D4E6 Q43066137-07788F9C-60E7-47C3-9ED5-67CB0FB05237 Q44979350-4DFE888A-1C33-43E7-A6DE-7FA392DF8081 Q47253158-51F52592-A81E-4F13-8C12-1A9D41CA1705 Q49130713-026B874C-7437-4A66-B7B7-2701300421C6 Q52723606-EB37C2E2-4418-4E52-B95D-CBC643CFF43E

P2860

Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

http://www.wikidata.org/entity/Q36092102

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@ast

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@en

type

label

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@ast

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@en

prefLabel

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@ast

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@en

P1433

Q36092102-48F764FF-B9E7-4EF6-B33D-17BD71C2BD93

P1476

Q36092102-7D9C988E-5134-4D47-B344-49E8E61DBB9E

P2093

Q36092102-35E65DEF-C976-402E-B4FB-FB11039D0C98

Q36092102-3C29FBF6-E600-44B6-950A-D37CFE7A4345

Q36092102-6B2B8006-D9DE-404C-9B3F-2F3D11A40A4A

Q36092102-AB98EFD5-1C40-4451-BCEB-C224409F109F

Q36092102-ACEAEC94-1B3B-4E40-A90F-011D1D41E67F

Q36092102-EC754D58-129C-43B9-B04E-2B11BA4E0F95

Q36092102-F7C84801-555E-42F5-B367-9B5B14263CF6

Q36092102-FF17B092-B165-4334-A6AF-234F895EE597

P2860

Q36092102-0750AFAA-69CA-4BB5-82C8-A94ADB4699F8

Q36092102-07F54FDB-5847-4A29-AB68-02241D09CE4F

Q36092102-09617F46-BF98-454F-940A-B4087154B506

Q36092102-0D687AED-1CD2-4F50-B4A9-71F0AA476867

Q36092102-0ECD4A90-6C61-4505-AE49-308E71FFCB1B

Q36092102-11D6FE24-E1BF-4436-93E8-39679A8B0BE5

Q36092102-13E3E851-E1EF-48BF-9895-EA29C2D7FA76

Q36092102-13FAAB4A-3B0C-41FE-B4DE-71100A78AB89

Q36092102-172084BC-D479-46DC-9492-F0BFD08622A3

Q36092102-1764F045-FDA5-4418-ACB8-5170A3C80FE6

P304

Q36092102-A8B452FC-B889-44D3-AD41-DCBF5865B587

P31

Q36092102-87104D6C-E961-4015-8FC1-E4A6446740E6

P356

Q36092102-DF6E8B7B-DDB0-4FF6-BCD3-9652DEC50399

P407

Q36092102-E43FF167-6FD5-47A2-B9CE-23573AE8B6CB

P433

Q36092102-FFE935DA-C830-4981-B774-47AA7BF08120

P478

Q36092102-E2CA473A-9496-44FD-979D-A0CA86F81106

P577

Q36092102-260F78B0-DF23-4E7C-B245-55C0CE1C307B

P5875

Q36092102-1310A5B4-4FB8-442E-A5AD-7AD56F62E4C9

P698

Q36092102-752F6D1F-4A9E-44E8-BCE4-5A8120859239

P932

Q36092102-3B80F1ED-0C42-47CC-B4E1-B948C7C834E6

P356

J.1365-2141.2012.09154.X

P1433

British Journal of Haematology

P1476

Macrophages and mesenchymal st ...... ion of multiple myeloma cells.

@en

P2093

Bridget A Dollar

http://www.w3.org/2001/XMLSchema#string

Fotis Asimakopoulos

http://www.w3.org/2001/XMLSchema#string

Jaehyup Kim

http://www.w3.org/2001/XMLSchema#string

Justin P Kuether

http://www.w3.org/2001/XMLSchema#string

Leah E Escalante

http://www.w3.org/2001/XMLSchema#string

Natalie S Callander

http://www.w3.org/2001/XMLSchema#string

Peiman Hematti

http://www.w3.org/2001/XMLSchema#string

Ryan A Denu

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Putting tumours in context

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation

Microenvironmental regulation of metastasis

The role of myeloid cells in the promotion of tumour angiogenesis

Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data.

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

A phase 2 study of bortezomib in relapsed, refractory myeloma.

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.

P304

336-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2012.09154.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224955991

http://www.w3.org/2001/XMLSchema#string

P698

22583117

http://www.w3.org/2001/XMLSchema#string

P932

3395762

http://www.w3.org/2001/XMLSchema#string